Manufacturers, packers and importers are now allowed to apply updated Maximum Retail Prices via stickers or stamps on unsold stock under new GST rules, mitigating packaging waste and easing the ...

Millrose Properties, Inc. engages in the provision of an operational and capital solution for home builders and land development. It finances the acquisition and development of land assets through its ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

The Deltek platform is differentiated by three core pillars that reflect the company’s purpose-built approach to serving complex, regulated industries. By unifying ERP and accounting, project ...

Millrose Properties (MRP) shares saw a slight uptick today, continuing a trend that has developed over the past month. Investors seem to be weighing the company’s recent financial performance and ...

Millrose Properties Inc (NYSE:MRP) generated $852 million in net cash proceeds from whole site sales, showcasing strong cash flow generation. The company successfully redeployed $858 million in new ...

Nigel Farage is on course to be prime minister, according to a seat-by-seat YouGov poll which reveals the scale of Conservative implosion. The YouGov MRP polling projection, based on a 13,000 sample ...

Mumbai: The ministry of consumer affairs has moved to ease compliance requirements for packaged goods companies ahead of the roll-out of the recent goods and services tax (GST) rate revisions. In a ...

Ice-cream manufacturers on Wednesday said they have decided to reduce prices of their products by 7-10 per cent, after the Goods and Services Tax (GST) on ice-creams was reduced to 5 per cent from the ...

New Delhi: The Modi government recently announced major GST reforms, aimed at making daily-use items more affordable for common people. The GST Council approved just two simplified tax rates — 5 ...

Drug manufacturers will not be required to recall or re-label medicines already released in the market before September 22, 2025, following the latest revision in Goods and Services Tax (GST) rates.